Kyle Gano, Chief Business Development Off: Neurocrine Biosciences NBIX Sell · Filed 24/01/04

Trade details

Type: Insider sale
Amount: $9,056,179.48
Shares · price: 68,884 sh · $131.47 a share
Held after: 130,250 sh
Stock: Neurocrine Biosciences NBIX
Person: Kyle GanoChief Business Development Off
Trade date: 24/01/02
Filed: 24/01/04
Days to filing: 2 days

Sold 34.6% of holdings

Share of holding sold: 34.6%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/12/03~24/02/01

Kyle Gano's recent trades

Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$4.6M
34,588 sh
$4.6M
Filed 01/20
Traded 01/16
Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$240.5K
1,812 sh
$240.5K
Filed 01/20
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$4.9M
36,400 sh
$4.9M
Filed 01/16
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/05
Traded 25/11/04
Kyle GanoCEO
SellNeurocrine Biosciences
Sell
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/04
Traded 25/11/04

Kyle Gano, Chief Officer — sold $9.1M of Neurocrine Biosciences NBIX · 34.6% of holdings · 10b5-1 plan | Whalegun